Widespread
adoption of mobile technology in healthcare, or mHealth, is now viewed
as inevitable in both developed and emerging markets around the world,
but the pace of adoption will likely be led by emerging markets and lag
consumer demand, according to new research commissioned by PwC Global
Healthcare. If the promise of mHealth is realized by consumers, the impact on healthcare delivery could be significant and fundamentally alter traditional relationships within the healthcare industry. Across the globe, the use of mHealth and speed of adoption will be determined in each country by stakeholders' response to mHealth as a disruptive innovation to overcome structural impediments and align interests around patients' needs and expectations. Despite demand and the obvious potential benefits of mHealth, rapid adoption is not occurring in 2012. The main barriers are not the technology but rather systemic to healthcare and inherent resistance to change. Though many people think mobile health will be ancillary or bolted on to the healthcare industry, PwC looks at it differently: mHealth is the future of healthcare, deeply integrated into delivery that will be better, faster, less expensive and far more customer-focused. Christopher Wasden, EdD, Global Healthcare Innovation Leader, PwC, tells us that "the adoption of mobile health in emerging markets versus developed markets is a paradox. In developed markets, mHealth is perceived as disrupting the status quo, whereas in emerging countries it is seen as creating a new market, full of opportunity and growth potential. In younger, developing economies, healthcare is less constrained by healthcare infrastructure and entrenched interests. Consumers are more likely to use mobile devices and mHealth applications, and more payers are willing to cover the cost of mHealth services." Please join PwC's Christopher Wasden on Tuesday, September 18th, 2012 as he presents detailed research findings and explores how stakeholders can overcome the barriers slowing widespread adoption of mHealth. In this session he will identify strategic considerations for companies active in the mHealth arena, and will discuss how stakeholders can help to alleviate healthcare's resistance to change by focusing less on the technology and more on effective, customer-focused solutions that add value for health organizations and patient quality of life. |
||||||||||||
Participants will be able to:
|
||||||||||||
Interested attendees would include:
Attendees would represent organizations including:
|
||||||||||||
|
||||||||||||
Return to HealthExecWire Archive Menu
|